Table 4 Results of the multiple linear regression models

From: Distribution and impact on quality of life of the pain modalities assessed by the King’s Parkinson’s disease pain scale

 

Adjusted R 2

Coeff.

SE

Significance

Beta

Model 1

     

 EQ-5D-3L index

0.43

    

  SCOPA-ADL

 

−0.022

0.007

0.001

−0.28

  HADS-Depression

 

−0.013

0.005

0.019

−0.18

  KPPS

 

−0.002

0.001

0.047

−0.17

Model 2

     

 PDQ-8 index

0.67

    

  HADS-Depression

 

2.51

0.29

<0.001

0.49

  SCOPA-ADL

 

1.43

0.36

<0.001

0.26

  PDSS-2

 

0.40

0.11

<0.001

0.22

Model 3

     

 EQ-5D-3L index

0.35

    

  Musculoeskeletal

 

−0.018

0.005

<0.001

−0.26

  Fluctuation-related

 

−0.008

0.003

0.002

−0.24

  PD duration

 

−0.012

0.004

0.003

−0.21

Model 4

     

 PDQ-8 index

0.31

    

  Nocturnal

 

0.68

0.26

0.01

0.20

  Discolouration, edema

 

0.81

0.38

0.03

0.18

  PD duration

 

0.70

0.29

0.02

0.17

  1. Coeff. coefficient, SESCOPA-ADL scales for outcomes in Parkinson’s disease-activities of daily living, HADS hospital anxiety and depression scales, KPPS King’s Parkinsons’ disease pain scale, PDSS-2 Parkinson’s Disease Sleep Scale-Version 2, PD Parkinson’s disease, PDQ-8 Parkinson’s disease questionnaire-8 items
Back to article page